AzTrials
AzTrials

Mild-to-Moderate Mandibular Anterior Crowding3D-BOT-RCTNCT07897864

Bracketless Orthodontic Treatment (3D-BOT) Versus Conventional Fixed Braces for Mild-to-Moderate Lower Front Tooth Crowding in Adults

A study testing Conventional Labial Fixed Orthodontic Appliance and 3D-BOT Using E-WIRE Archwires in people with Mild-to-Moderate Mandibular Anterior Crowding, run by University of Aleppo at 1 site in Syria.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will compare two fixed orthodontic treatments for mild-to-moderate crowding of the lower front teeth in adults. Participants will be randomly assigned to three-dimensional bracketless orthodontic treatment (3D-BOT), which uses wires bonded directly to the teeth, or conventional braces attached to the front… Read more about this study

Who is it for?
Ages 18 to 25 years
What is being tested?
Conventional Labial Fixed Orthodontic Appliance and 3D-BOT Using E-WIRE Archwires
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSyria
Study dates
15 Nov 2026to 15 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-25 years, inclusive.
  • Little's Irregularity Index of 3-6 mm in the mandibular anterior segment (FDI teeth 43-33), measured on the pretreatment digital model.
  • Permanent dentition with clinically stable occlusion and an Angle Class I molar relationship.
  • Skeletal Class I relationship, defined by an ANB angle of 1-4° on the pretreatment lateral cephalogram.
  • Presence of all mandibular teeth from the right second molar to the left second molar (47-37); third molars are not required.
  • Suitability for non-extraction orthodontic treatment, with the possibility of deferring maxillary orthodontic treatment until completion of the participant's study follow-up.
  • Acceptable oral and periodontal health on pretreatment clinical examination, with a mean Plaque Index (PI) score ≤1 and no periodontitis.
  • No active caries, extensive enamel lesions, extensive restorations or prosthetic crowns affecting the tooth surfaces required for bonding either study appliance.

Who cannot join

  • Previous orthodontic treatment.
  • Severe bruxism or a habit of biting hard objects.
  • Deep bite precluding placement of either study appliance without occlusal interference.
  • Use of medications or presence of systemic conditions that clearly affect tooth movement or periodontal health.
  • Known hypersensitivity to nickel or resin-based bonding materials.
  • Craniofacial syndromes or malformations, including cleft lip and/or palate.
  • Severe vertical or transverse skeletal discrepancies.
  • Inability to attend scheduled follow-up visits throughout the study period.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Suleiman Habeeb AL-Mohrez, MSc student contact

+963991993341

suleiman.habeeb.almohrez@gmail.com

Feras Baba, PhD contact

+963955590631

ferasbaba72@gmail.com

Syria1 site
  • Faculty of Dentistry, University of Aleppo

    Aleppo, Aleppo Governorate

    Suleiman Habeeb AL-Mohrez, MSc student, +963991993341, suleiman.habeeb.almohrez@gmail.com

Other trials in Syria

About this study

Official title: Clinical and Digital Evaluation of the Effectiveness of Three-Dimensional Bracketless Orthodontic Treatment (3D-BOT) Using E-WIRE Archwires Versus Conventional Fixed Orthodontic Treatment: A Randomized Controlled Clinical Trial

This study will compare two fixed orthodontic treatments for mild-to-moderate crowding of the lower front teeth in adults. Participants will be randomly assigned to three-dimensional bracketless orthodontic treatment (3D-BOT), which uses wires bonded directly to the teeth, or conventional braces attached to the front surfaces of the teeth.

The main aim is to compare how tooth alignment changes during the first 24 weeks after appliance placement. Additional assessments will examine changes in tooth position and lower dental arch dimensions, oral and gum health, soft-tissue effects, quality of life and psychosocial well-being, patient experience and satisfaction, pain and painkiller use, appliance failures, time spent on clinical procedures and digital preparation, and changes in teeth and supporting bone. Data will be collected through clinical examinations, digital scans, questionnaires, home diaries and radiographic imaging.

Read the detailed description

Adult orthodontic treatment requires a balance between alignment effectiveness, appliance visibility, comfort, oral hygiene, and treatment burden. Conventional fixed appliances do not depend on daily wear of a removable appliance, whereas clear aligners require adherence to prescribed wear. Three-dimensional bracketless orthodontic treatment (3D-BOT) aims to combine digitally planned, fixed wire-based mechanics with less conspicuous appliance placement. Its proposed clinical and patient-related advantages require comparative evaluation.

Recruitment process: Participants will be recruited consecutively from adults aged 18-25 years seeking treatment for mandibular anterior crowding at the Department of Orthodontics, Faculty of Dentistry, University of Aleppo. Potentially eligible patients will receive a verbal explanation and a written information sheet covering the study, both interventions, risks, anticipated benefits, follow-up requirements and voluntary participation, with an opportunity to ask questions. Written informed consent will be obtained before study-specific baseline procedures, and declining participation will not affect routine care. Final eligibility will be confirmed using Little's Irregularity Index measured on the pretreatment digital model.

Both groups will be managed using common pretreatment planning principles and clinical limits. The digital target setup and interproximal reduction (IPR) plan will be finalized before allocation disclosure; appliance-specific wire-position planning for 3D-BOT will follow allocation. In the 3D-BOT group, planned anterior fixation sites will be transferred clinically using each clinical crown's lingual long axis and the digitally recorded vertical distance from the wire centre to the incisal edge or canine cusp tip, with a bracket-positioning gauge and marker. Posterior wire positioning will use the central occlusal fossae and grooves as reference landmarks. Planned and delivered IPR will be documented separately, and subsequent clinically justified plan revisions will be dated and retained alongside the original plan.

At scheduled visits, research records and questionnaires will be obtained before appliance adjustment, replacement, or repair, and oral health assessments will precede professional cleaning. Digital scans will follow a standardized acquisition sequence, recording both arches and the bite at baseline and the mandibular arch only at follow-up. Scan completeness will be verified before files are saved in STL format under coded names in a separate research folder for each participant. Standardized measurement procedures will be applied to coded digital models and lateral cephalograms. Intra-assessor reliability and measurement error will be assessed through repeated measurements on a randomly selected subset of records, without access to previous readings. Patient-reported assessments will follow standardized instructions and instrument-specific recall periods. Pain and analgesic diaries will be anchored to actual appliance placement or activation.

Treatment progression will be guided by clinical suitability. Actual treatment received will be recorded, together with the timing and reasons for delays, repairs, rescue interventions, and deviations from the planned sequence. Discontinuation or modification of the assigned appliance will be distinguished from withdrawal of consent for research follow-up. Participants who discontinue or change their appliance will be invited to continue scheduled assessments if they consent. The primary analysis will follow the intention-to-treat principle, retaining the original randomized allocation, with prespecified handling of missing data and sensitivity analyses addressing protocol adherence and missing-data assumptions.

Being tested
Conventional Labial Fixed Orthodontic Appliance, 3D-BOT Using E-WIRE Archwires
Keywords
Bracketless orthodontics, 3D-BOT, E-WIRE, Mandibular anterior crowding, Fixed orthodontic appliances, Digital treatment planning, Little's Irregularity Index, Randomized controlled trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional Labial Fixed Orthodontic ApplianceDevice

    Mini Master Series metal brackets (American Orthodontics), MBT prescription with 0.022-inch slots, will be bonded to teeth 45-35, with buccal tubes on 46 and 36. Nickel-titanium (NiTi) archwires will follow the planned sequence (inches): 0.012 at APP0; 0.014 after T1 (Week 4); 0.016 after T2 (Week 8); 0.016×0.022 after T3 (Week 12); 0.017×0.025 after T4 (Week 16); and 0.019×0.025 at Week 20. Progression requires clinically appropriate engagement without excessive force; otherwise, the current wire will be retained and reassessed. A 0.019×0.025-inch stainless steel wire will be placed after all T5 (Week 24) research assessments. IPR will follow the plan locked before randomization. No chains, springs or other auxiliaries directly affecting lower anterior alignment will be used during evaluation. Actual wire changes, delays, repairs and clinically necessary deviations will be documented.

  • 3D-BOT Using E-WIRE ArchwiresDevice

    At APP0, a round coated E-WIRE (E-Wireligner; nominal size 0.014 inch) will be secured with GC Ortho Connect Flow (GC Orthodontics) from teeth 46 to 36 along a digitally planned posterior occlusal/anterior lingual path. After light curing, the water-soluble coating will be removed with a 60-second water wash. After the T2 (Week 8) digital scan, the initial wire and its composite will be removed, and a coated Velodrome E-WIRE (E-Wireligner; nominal size 0.016 × 0.022 inch) will be bonded to the lingual surfaces of teeth 43-33 only, using the same bonding and coating-removal procedures. IPR will follow the plan locked before randomization. No auxiliaries directly affecting lower anterior alignment will be used. Clinically necessary delays, repairs and deviations will be documented.

Study groups in NCT07897864
Study groupRoleWhat they receive
Conventional Labial Fixed Orthodontic TreatmentActive comparatorParticipants will receive conventional labial fixed orthodontic treatment using metal brackets and a planned archwire sequence to align the mandibular anterior teeth.
Receives: Device: Conventional Labial Fixed Orthodontic Appliance
3D-BOT Using E-WIRE ArchwiresExperimentalParticipants will receive bracketless fixed orthodontic treatment using coated E-WIRE archwires secured with composite along a digitally planned path to align the mandibular anterior teeth.
Receives: Device: 3D-BOT Using E-WIRE Archwires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Longitudinal change in mandibular anterior Little's Irregularity Index (LII)

    LII is the sum of five horizontal displacements between corresponding anatomical contact points of adjacent mandibular anterior teeth (43-33), measured in millimeters on digital models. Decreases from baseline indicate improved alignment.

    Measured: Baseline (T0, before initial appliance placement) and Weeks 4, 8, 12, 16 and 24 after initial appliance placement (APP0).

Secondary outcomes (18)
  1. Alignment Progression and Time to Documented Alignment

    Mandibular anterior alignment is assessed on digital models using Little's Irregularity Index (LII). Measures include interval LII reduction (mm), improvement rate (mm per four weeks, using scheduled interval durations), cumulative percentage improvement from baseline, proportion achieving LII ≤1 mm, and time (days) from initial appliance placement to the first scan documenting LII ≤1 mm.

    Measured: Baseline and Weeks 4, 8, 12, 16 and 24 after initial appliance placement. Time to documented alignment: from initial placement up to Week 24.

  2. Changes in mandibular arch dimensions

    Digital-model changes from baseline (mm) in intercanine cusp-tip width, first-premolar Pont width, first-molar middle-buccal-cusp width and anterior arch depth. Pont points lie at the distal marginal ridge/distal buccal-cusp-slope junctions. Depth is the greatest perpendicular distance from either lower central incisor's most labial incisal-edge point to the first-premolar Pont line.

    Measured: Baseline and Weeks 4, 8, 12, 16 and 24 after initial placement.

  3. Changes in lower incisor inclination and protrusion

    Changes from baseline on lateral cephalograms in the angles between the lower incisor's long axis and the mandibular plane (Go-Me) and nasion-point B line (NB), measured in degrees, and the perpendicular distance from its most labial crown point to NB, measured in millimeters.

    Measured: Baseline and Week 24 after initial placement, before treatment procedures.

  4. Mandibular anterior rotation correction

    Crown-axis angular deviations of the six lower anterior teeth from the digital target setup approved before randomization, measured in the reference occlusal plane. The main indicator is mean absolute error (MAE; degrees); root mean square error (RMSE; degrees) and percentage reduction from baseline MAE are supportive indicators. Lower angular errors indicate closer agreement with the target.

    Measured: Baseline and Weeks 4, 8, 12, 16 and 24 after initial placement.

  5. Mean Silness-Löe Plaque Index Score

    Mean Plaque Index score (0-3) across up to 48 sites on mandibular teeth 46-36. The mean is calculated from the sites actually assessed, with the number of assessed sites recorded. Higher scores indicate greater plaque accumulation.

    Measured: Baseline and Weeks 4, 12 and 24 after initial appliance placement, before cleaning or treatment procedures.

  6. Mean Löe-Silness Gingival Index Score

    Mean Gingival Index score (0-3) across up to 48 sites on mandibular teeth 46-36. The mean is calculated from the sites actually assessed, with the number of assessed sites recorded. Higher scores indicate greater gingival inflammation.

    Measured: Baseline and Weeks 4, 12 and 24 after initial appliance placement, before cleaning or treatment procedures.

  7. Mean Papillary Bleeding Index Score

    Mean Mühlemann Papillary Bleeding Index score (0-4) across up to 22 buccal and lingual papillary sides in the mandibular region 46-36. The mean is calculated from the papillary sides actually assessed, with the number assessed recorded. Higher scores indicate greater papillary bleeding.

    Measured: Baseline and Weeks 4, 12 and 24 after initial appliance placement, before cleaning or treatment procedures.

  8. Number and Percentage of Calculus-Positive Surfaces (Calculus Surface Index)

    Number and percentage of calculus-positive surfaces on the four mandibular incisors (42, 41, 31 and 32), assessed on four surfaces per tooth (labial, lingual, mesial and distal). The count ranges from 0 to 16 when all surfaces are assessed; the percentage uses the number of surfaces actually assessed as its denominator. Higher values indicate more calculus.

    Measured: Baseline and Weeks 4, 12 and 24 after initial appliance placement, before cleaning or treatment procedures.

  9. Oral health-related quality of life

    Arabic-language Oral Health Impact Profile-14 (OHIP-14), with a total score of 0-56 and a preceding-month recall period; higher scores indicate worse impact. Four separate descriptive indicators-oral function, orofacial pain, orofacial appearance and psychosocial impact-each range from 0-8.

    Measured: Baseline and Weeks 4, 8, 12, 16, 20 and 24 after initial placement, before clinical procedures.

  10. Psychosocial impact of dental aesthetics

    Arabic Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ-Ar): 23 items, with six dental self-confidence items reverse-scored, yielding a total of 0-92. Higher scores indicate worse psychosocial impact. Assessments characterize changes during treatment, with the appliance present at the final assessment.

    Measured: Baseline, Day 7, and Weeks 4, 12 and 24 after initial appliance placement; clinic assessments before treatment procedures.

  11. Patient Experience and Satisfaction Assessed by Visual Analogue Scales

    Study-specific 0-100 mm visual analogue scales assess appliance-related symptoms and functional and social impacts over the preceding 24 hours. Appliance-related satisfaction and willingness to choose the same appliance again or recommend it are assessed at Week 24 based on the participant's experience to date. Each item is analyzed separately; no overall score is calculated. Higher symptom and impact scores indicate worse experience, whereas higher satisfaction and willingness scores indicate more favorable responses.

    Measured: Experience: Days 1/7 and Weeks 4/12/24 after initial placement; also 24 h/7 days after the first non-round wire (planned Week 8 for 3D-BOT; Week 12 for control; actual dates used). Satisfaction: Week 24. Clinic ratings precede procedures.

  12. Pain Intensity, Burden and Interference

    Pain intensity is assessed using a 0-10 Numerical Rating Scale (0=no pain; 10=worst imaginable pain). Initial-placement pain burden is the trapezoidal area under the scheduled pain scores from 4 to 168 hours (score × hours), excluding the pre-procedure reading. Separate 0-10 ratings assess pain interference with sleep, mood, work/study and social life over the preceding seven days. Higher scores indicate greater pain or interference.

    Measured: Before initial placement/actual activation and 4, 24, 48, 72, 96, 120, 144 and 168 hours later; interference at Day 7. Sessions occur through Week 24. Initial-placement pain burden: 4-168 hours.

  13. Analgesic Use, Dose and Time to First Dose

    Measures include any analgesic use, number of days of use, number of doses, cumulative dose (mg) for each drug, and time to the first dose after the procedure. Different drugs are recorded and summarized separately. Analgesic use during the preceding 24 hours is recorded separately.

    Measured: During the 24 hours before and seven days after initial appliance placement and each actual activation through Week 24.

  14. Clinical procedure, digital preparation time and treatment burden

    The main comparison is cumulative net clinical procedure time (minutes), including initial application, planned procedures and repairs/unplanned interventions, but excluding isolation, interproximal reduction and non-procedural pauses. Initial application, planned-procedure and repair times are also reported separately. Additional 3D-BOT digital setup and wire-planning time is described separately and added to clinical time for a supplementary total; control-group research-only setup is excluded. Cumulative clinical time, unplanned visits, repair counts and repair time are additionally summarized up to the first scan documenting Little's Irregularity Index ≤1 mm, excluding subsequent procedures at that visit. Non-achievement by Week 24 is recorded.

    Measured: Planning through completion of Week 24 procedures, including final wire placement. Alignment-target burden ends before treatment at the first qualifying scan documented by Week 24.

  15. Clinical appliance failure and failure patterns

    Clinically confirmed unplanned loss of appliance stability or mechanical integrity requiring intervention. Outcomes include the proportion with failure, event counts and days to first failure. Events are classified by type, site, suspected cause, wire stage and same-site recurrence. A fixation unit is a bonded bracket/tube in conventional treatment or a composite fixation point in 3D-BOT. Each failed unit and recurrence after repair counts separately. Unit-related failure rates are expressed as events per fixation-unit-week of exposure. Failure timing is classified relative to the most recent placement or rebonding of the affected unit: immediate (0-24 hours), early (>24 hours to four weeks), or late (>four weeks). Time to the participant's first failure is measured from initial appliance placement and does not reset after repair or wire replacement.

    Measured: Initial appliance placement through the Week 24 assessment, before treatment procedures.

  16. Incidence and Severity of New Oral Mucosal Lesions

    Proportion developing new lesions, new-lesion count, maximum clinically assessed severity on a study-specific 0-4 scale (0=no lesion; 4=severe/multiple ulceration, marked speech/chewing difficulty or medication requirement), maximum diameter (mm), speech/chewing effects, medication need and percentage of scheduled assessments with lesions. Pre-existing lesions are recorded separately; persistent lesions count once and recurrence after resolution counts as new.

    Measured: Baseline; Days 1 and 7; Weeks 4, 8, 12, 16, 20 and 24 after initial placement, plus interim monitoring. Follow-up ends before Week 24 treatment procedures.

  17. External root resorption of mandibular anterior teeth

    Root shortening of the six mandibular anterior teeth, calculated as baseline root length minus Week 24 root length (mm) on paired cone-beam computed tomography images. Results are summarized per tooth and as the participant-level mean across evaluable teeth; the number of teeth assessed is recorded.

    Measured: Baseline and Week 24 after initial appliance placement.

  18. Changes in mandibular anterior alveolar bone

    Changes from baseline in buccal, lingual and interradicular bone thickness and alveolar crest level (mm) around the six mandibular anterior teeth, assessed using cone-beam computed tomography, together with the number and proportion of assessable sites showing radiographic dehiscence or fenestration. Non-assessable sites are documented.

    Measured: Baseline and Week 24 after initial appliance placement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2026
  2. Study start15 Nov 2026 (estimated)
  3. Primary completion15 Jun 2028 (estimated)
  4. Study completion15 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel, two-arm RCT, 1:1 (15 per group).
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07897864
Sponsor's protocol ID
AU-ORTHO-3DBOT-2026
Acronym
3D-BOT-RCT
Status last verified
Oct 2026
First submitted
20 Oct 2026
Last updated
27 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Alharbi RA, Eshky RT, Marae SO, Hifnawy T, Alsulaimani M. Translation and validation of the Arabic version of the Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ). J Orthod Sci. 2020 Nov 2;9:19. doi: 10.4103/jos.JOS_34_20. eCollection 2020.

    PubMed 33354545
  • Al-Jundi MA, Szentpetery A, John MT. An Arabic version of the Oral Health Impact Profile: translation and psychometric properties. Int Dent J. 2007 Apr;57(2):84-92. doi: 10.1111/j.1875-595x.2007.tb00443.x.

    PubMed 17506467
  • Kara-Boulad JM, Burhan AS, Hajeer MY, Khattab TZ, Nawaya FR. Evaluation of the Oral Health-Related Quality of Life (OHRQoL) in Patients Undergoing Lingual Versus Labial Fixed Orthodontic Appliances: A Randomized Controlled Clinical Trial. Cureus. 2022 Mar 22;14(3):e23379. doi: 10.7759/cureus.23379. eCollection 2022 Mar.

    PubMed 35371870
  • Kusaibati AM, Sultan K, Hajeer MY, Gkantidis N. Digital setup accuracy for moderate crowding correction with fixed orthodontic appliances: a prospective study. Prog Orthod. 2024 Apr 8;25(1):13. doi: 10.1186/s40510-024-00513-7.

    PubMed 38584176
  • Keerthana P, Chitra P. Alleviation of Lower Anterior Crowding with Super- Elastic and Heat-Activated NiTi Wires: A Prospective Clinical Trial. Turk J Orthod. 2021 Jun;34(2):127-135. doi: 10.5152/TurkJOrthod.2021.20084.

    PubMed 35110162
  • Alzainal MH, Warunek S, Covell DA Jr, Tanberg W, Aliaga-Del Castillo A, Cevidanes L, Al-Jewair T. Efficacy and Comfort Level with the Non-Sliding Lingual Orthodontic Technique (BRIUS) Versus Labial Full Fixed Appliances: A Pilot Randomized Controlled Clinical Trial. Dent J (Basel). 2024 Nov 18;12(11):368. doi: 10.3390/dj12110368.

    PubMed 39590418
  • Papageorgiou SN, Golz L, Jager A, Eliades T, Bourauel C. Lingual vs. labial fixed orthodontic appliances: systematic review and meta-analysis of treatment effects. Eur J Oral Sci. 2016 Apr;124(2):105-18. doi: 10.1111/eos.12250. Epub 2016 Feb 25.

    PubMed 26916846
  • Liu C, Wei Z, Jian F, McIntyre G, Millett DT, Lai W, Wang Y. Initial arch wires used in orthodontic treatment with fixed appliances. Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD007859. doi: 10.1002/14651858.CD007859.pub5.

    PubMed 38319008
  • Alqaisi NN, Hadad RA, Alsilq MN. Bracketless three-dimensional orthodontic treatment using coated nickel-titanium E-wires for mild-moderate anterior crowding: A case report with 6-month follow-up. J Int Med Res. 2026 May;54(5):3000605261444867. doi: 10.1177/03000605261444867. Epub 2026 May 4.

    PubMed 42082448
  • Little RM. The irregularity index: a quantitative score of mandibular anterior alignment. Am J Orthod. 1975 Nov;68(5):554-63. doi: 10.1016/0002-9416(75)90086-x.

    PubMed 1059332

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Labial Fixed Orthodontic Appliance and 3D-BOT Using E-WIRE Archwires in people with Mild-to-Moderate Mandibular Anterior Crowding, run by University of Aleppo at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Suleiman Habeeb AL-Mohrez, MSc student (+963991993341, suleiman.habeeb.almohrez@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Longitudinal change in mandibular anterior Little's Irregularity Index (LII) (time frame: Baseline (T0, before initial appliance placement) and Weeks 4, 8, 12, 16 and 24 after initial appliance placement (APP0).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07897864, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in